We, therefore, studied the effect of KCa3.1 targeting on the survival of tumor-transplanted mice, on the tumor dissemination in the brain, and on the immune-microenvironment in a syngeneic orthotopic glioma mouse model. Here, KCNN4 is linked to central nervous system cancer.